Merck: FDA won't accept its application for combo cholesterol pill including Pfizer's Lipitor

Nov 2nd, 2009 - ChicagoTribune

Related content:

TRENTON, N.J. (AP) - U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug.

Merck disclosed the rare move by the Food and Drug Administration in a regulatory filing Monday.

The company 2 1/2 years ago said it planned to make a dual cholesterol pill that at the time looked sure to be a blockbuster: a combination of Pfizer Inc.'s Lipitor - which generates nearly $13 billion in annual sales - and Zetia, a cholesterol pill Merck sells with Schering-Plough Corp. The two drugmakers have been partners on cholesterol medicines since 2000 and are about to merge.

Read the whole story on ChicagoTribune or try our Toolbar
Bookmark and Share
blog comments powered by Disqus

Related stories:

  • Merck to complete $41B purchase of Schering-Plough

    Nov 3rd, 2009 - Houston Chronicle

    WHITEHOUSE STATION, N.J. — Merck & Co. is set to complete its $41 billion acquisition of Schering-Plough Corp. later Tuesday, creating the world's second-largest drugmaker...

  • FDA won't accept Merck's application for new drug

    Nov 2nd, 2009 - Forbes

    WHITEHOUSE STATION, N.J. -- U.S. regulators won't accept drugmaker Merck's application for a new combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck & Co...

  • Merck's buy of Schering-Plough gets FTC approval

    Oct 29th, 2009 - Boston

    NEW YORK—Merck & Co. and Schering-Plough Corp. said Thursday they have won merger approval from the Federal Trade Commission and antitrust regulators in Switzerland and Canada.

  • Freeport-McMoRan to move into S&P 100 index

    Oct 29th, 2009 - sacbee

    NEW YORK -- Standard & Poor's said Thursday it will add miner Freeport-McMoRan Copper & Gold Inc. to its S&P 100 index to replace Schering-Plough Corp., after the drugmaker merges with Merck & Co...

  • EU approves Merck's takeover of Schering-Plough

    Oct 24th, 2009 - The Denver Post

    BRUSSELS — The European Union approved Merck & Co.'s proposed takeover of Schering-Plough, which would create the second-biggest global producer of prescription medicines.

More stories ...

Related videos from YouTube:

More videos ...

Google Search: